Premium
Release of tissue‐type plasminogen activator is induced in rats by leukotrienes C 4 and D 4 , but not by prostaglandins E 1 , E 2 and I 2
Author(s) -
Tranquille N.,
Emeis J.J.
Publication year - 1988
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1988.tb11417.x
Subject(s) - prostacyclin , leukotriene d4 , leukotriene , leukotriene c4 , plasminogen activator , medicine , endocrinology , chemistry , platelet activating factor , prostaglandin , platelet , fibrin , t plasminogen activator , antagonist , fibrinolysis , in vivo , receptor , biology , immunology , asthma , microbiology and biotechnology
1 Acute release of plasminogen activator (PA) was studied in rat isolated hindleg system perfused with Tyrode solution. 2 Leukotriene C 4 (LTC 4 ) and LTD 4 dose‐dependently induced the release of PA, which plateaued at 160 nmol l −1 and 200 nmol l −1 , respectively. The amount of PA released was about 1 iu ml −1 . The effects of LTC 4 and LTD 4 were not additive. 3 The PA released was identified as tissue‐type PA (t‐PA) by quenching experiments using anti‐human t‐PA IgG, by fibrin autography, and by the dependence of its activity on the presence of soluble fibrin. 4 LTE 4 (300 and 450 nmol l −1 ) and 5‐hydroxy‐eicosatetraenoic acid (600 nmol l −1 ) did not induce any t‐PA release in the perfusion system used. 5 Release of t‐PA induced by LTC 4 and LTD 4 was inhibited by the leukotriene‐receptor antagonist FPL 55712 (10 μmol l −1 ), whereas FPL 55712 did not inhibit t‐PA release induced by platelet‐activating factor (Paf‐acether). 6 In vivo LTC 4 and LTD 4 (2 μg kg −1 i.v.) also induced an acute increase of t‐PA activity in rat blood as evidenced by decreased blood clot lysis times. 7 Prostaglandin E 1 and E 2 , prostacyclin and the stable prostacyclin analogue ZK 36374 at concentrations of 0.1–3.0 μmol l −1 induced little or no t‐PA release.